PLX647 is primarily utilized in research settings to study and modulate specific signaling pathways, particularly those involving kinases. It is often employed in preclinical studies to investigate its potential therapeutic effects in neurological disorders, including neurodegenerative diseases and pain management. Researchers use PLX647 to explore its ability to inhibit certain kinases that play a role in inflammation and neuronal signaling, aiming to develop targeted treatments for conditions like Alzheimer's disease, Parkinson's disease, and chronic pain. Its application extends to understanding the molecular mechanisms underlying these diseases and evaluating its efficacy in animal models to pave the way for future clinical trials.